Newsroom

Newsroom

Is It Validated?

Blog
Read More

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Press Release
Read More

NeoGenomics Announces Board Appointments

Press Release
Read More

Liquid Biopsy Testing for PIK3CA Mutation

Blog
Read More

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Press Release
Read More

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Press Release
Read More

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Press Release
Read More

A spotlight on CDx development

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients